Composition and method for the treatment of sickle cell anemia

Details Composition and method for the treatment of sickle cell anemia Composition and method for the treatment of sickle cell anemia

1992-02-14

1993-07-06

Dees, Jose G.

Drug, bio-affecting and body treating compositions

Anemia

Sickle cell

514627, 514560, 514549, 514552, 554 61, 554213, 554227, 4241951, A61K 3120

Patent

active

052254470

ABSTRACT:
The major component of the carbonate fraction of free acids extractable from alfalfa has shown excellent control of symptoms in patients with sickle cell disease. Its structure has been established by proton NMR spectrometry as being 16-hydroxy-9Z,12Z,14E-octadecatrienoic acid and closely related compounds, such as simple esters, amides, triglycerides, or other derivatives of the carboxylic acid function, and a method for its synthesis from linseed oil or methyl linolenate has been developed. The product from linseed oil, both in the form of the initially formed triglyceride and in the form of its free acid obtained by saponification, is useful for the treatment of sickle cell disease.

REFERENCES:
patent: 4473559 (1984-09-01), Robinson

Affiliated with

Also associated with

Rating

Composition and method for the treatment of sickle cell anemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for the treatment of sickle cell anemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for the treatment of sickle cell anemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1689884